This company has been marked as potentially delisted and may not be actively trading. Interpace Biosciences (IDXG) News Today Add Compare Share Share Headlines Stock AnalysisCompetitorsEarningsHeadlinesTrendsBuy This Stock All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 Time Period Effective May 2, 2025, Interpace Diagnostics® Will No Longer Accept Specimens for PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer RiskApril 24 at 4:00 PM | globenewswire.comPDI: Its Mega-Yield Party Was Over Years AgoApril 21, 2025 | seekingalpha.comPDI: A Golden Buying OpportunityApril 10, 2025 | seekingalpha.comPTY Vs. PDI: This Is The Wrong Time For PDIApril 8, 2025 | seekingalpha.comWestport Fuel Systems Reports Mixed Q4, Reveals Light-Duty Segment SaleMarch 31, 2025 | benzinga.comPIMCO March 2025 Update | PDI Gets Rich, PAXS/PFN/PHK CheaperMarch 22, 2025 | seekingalpha.comPDI Technologies Presents “The Retail Marketeers European Female Leaders in Convenience Awards”March 6, 2025 | financialpost.comFixed Income Looks Undervalued - Cash In With 13%-Yielding PDIFebruary 14, 2025 | seekingalpha.comPDI: Buy For The Yield And FlexibilityFebruary 12, 2025 | seekingalpha.comPDI's Yield Exceeding 13% Still Looks Inexpensive As Shares Continue HigherFebruary 12, 2025 | seekingalpha.comSPDI Transfers Ukrainian Property to Arcona Fund, Strengthening Market PositionFebruary 6, 2025 | tipranks.comPDI: Buy For A Double-Digit Yield And You May Even Beat The S&P 500February 5, 2025 | seekingalpha.comInterpace Biosciences, Inc.: Interpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business ResultsJanuary 31, 2025 | finanznachrichten.deInterpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2024 Financial and Business ResultsJanuary 31, 2025 | globenewswire.comInterpace Biosciences, Inc.: PancraGEN Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring PlanJanuary 27, 2025 | finanznachrichten.dePancraGEN® Will Continue to be Offered While Interpace Re-evaluates its Previously Announced Re-structuring PlanJanuary 27, 2025 | globenewswire.comPaycor HCM Inc (PYCR) Partners with PDI Technologies to Enhance Workforce Management SolutionsJanuary 22, 2025 | gurufocus.comDirt Cheap 14% Yield: PDIJanuary 11, 2025 | seekingalpha.comEffective 02/07/2025, Interpace Diagnostics® to No Longer Offer PancraGEN®, a Molecular Diagnostic Test That Assesses Pancreatic Cyst Cancer RiskJanuary 9, 2025 | globenewswire.comPDI: The Premium Has Come Down On This High Yielding CEFJanuary 2, 2025 | seekingalpha.comPDI: Collecting A Double Digit Yield With A Positive OutlookJanuary 2, 2025 | seekingalpha.comSecure Property Development & Investment PLC Reports Successful AGM ResolutionsDecember 30, 2024 | tipranks.comPDO Vs. PDI: Which One Of These Double-Digit Yielding Funds Is The Better Buy?December 10, 2024 | seekingalpha.comCorpay Inc (CPAY) Announces Sale of Comdata Merchant Solutions to PDI TechnologiesDecember 2, 2024 | gurufocus.comPDI: Avoid This 14% YieldNovember 30, 2024 | seekingalpha.comPDI Vs. Peers: Double-Digit Yield But Still UnderperformingNovember 29, 2024 | seekingalpha.comPDI: Beware The Massive NAV PremiumNovember 13, 2024 | seekingalpha.comInterpace Biosciences Inc.November 9, 2024 | wsj.comInterpace Biosciences Reports Impressive Q3 2024 GrowthNovember 7, 2024 | markets.businessinsider.comInterpace Biosciences Announces Record Third Quarter 2024 Financial and Business ResultsNovember 4, 2024 | globenewswire.comPDI: The Big ROC Bath, 13.5% 'Yield'October 27, 2024 | seekingalpha.comInterpace Biosciences Announces Capital Restructuring of Its Preferred Stock as a First Step Toward Seeking an Uplisting of Its Common Stock to NasdaqOctober 15, 2024 | globenewswire.comHealthcare Stocks Pre-Market MoversOctober 13, 2024 | benzinga.comPF42.SG,0P00019E71,0 (PF42.SG)August 21, 2024 | finance.yahoo.comInterpace Biosciences Announces Record Second Quarter 2024 Financial and Business ResultsAugust 1, 2024 | globenewswire.comInterpace Diagnostics® Announces Undefined Extension of Medicare Coverage for PancraGEN®, a Molecular Diagnostic Test That Assesses Cancer Risk of Pancreatic CystsJuly 29, 2024 | globenewswire.comPDI: PIMCO Vs. BlackRock, 10 Big-Yield CEFs ComparedJuly 21, 2024 | seekingalpha.comPDI: Get In Before The Fed Pivots And Lock In A 14% YieldJuly 13, 2024 | seekingalpha.comPDI: I Sold A Chunk Of The Position But I Am Still Bullish On This Fund Going ForwardJuly 2, 2024 | seekingalpha.comInterpace Biosciences Announces First Quarter 2024 Financial and Business ResultsMay 9, 2024 | globenewswire.comPDI Under $20 Exceeds A 13% Yield With Potential Upside On The HorizonApril 3, 2024 | seekingalpha.comInterpace Biosciences announces preliminary Q4 revenue of $10.3MMarch 7, 2024 | msn.comInterpace Biosciences Announces Preliminary Full-year and Fourth Quarter 2023 Financial and Business ResultsMarch 7, 2024 | globenewswire.comPDI: What Lurks Under The Hood Of PIMCO's Crown JewelMarch 1, 2024 | seekingalpha.comInterpace Biosciences Stock (OTC:IDXG) Dividends: History, Yield and DatesFebruary 22, 2024 | benzinga.comPDI: 14% Yield, But Risks Are Rising (Rating Downgrade)January 24, 2024 | seekingalpha.comPDI Looks Like It Bottomed And Is Still Yielding Over 14%January 9, 2024 | seekingalpha.comPDI: Lag Likely To ContinueDecember 5, 2023 | seekingalpha.comInterpace Biosciences Announces Record Third Quarter 2023 Financial and Business ResultsNovember 8, 2023 | finance.yahoo.comPDI: Pain Could Be On The HorizonOctober 24, 2023 | seekingalpha.com Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address IDXG Media Mentions By Week IDXG Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IDXG News Sentiment▼0.000.94▲Average Medical News Sentiment IDXG News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IDXG Articles This Week▼20▲IDXG Articles Average Week Get Interpace Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for IDXG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Quest Diagnostics News Today Laboratory Co. of America News Today DaVita News Today Chemed News Today CorVel News Today Amedisys News Today Pediatrix Medical Group News Today AMN Healthcare Services News Today Cross Country Healthcare News Today GBS News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IDXG) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Interpace Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Interpace Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy IDXG Stock Free IDXG Stock Alerts